shot-button
Subscription Subscription
Home > Sports News > Cricket News > Article > IND vs SL Axar Patel replaces Kuldeep Yadav in India squad for second Test

IND vs SL: Axar Patel replaces Kuldeep Yadav in India squad for second Test

Updated on: 08 March,2022 07:18 AM IST  |  Bangalore
PTI |

Axar had been recovering from a shin injury that had forced him to miss the South Africa tour and the T20 series against West India. He had also tested positive for COVID-19 recently

IND vs SL: Axar Patel replaces Kuldeep Yadav in India squad for second Test

Axar Patel. Pic/PTI

Fit-again all-rounder Axar Patel has replaced left-arm wrist spinner Kuldeep Yadav for India’s second Test against Sri Lanka, beginning here on Saturday.
The Indian team management has released Kuldeep from the squad.


Axar had been recovering from a shin injury that had forced him to miss the South Africa tour and the T20 series against West India. He had also tested positive for COVID-19 recently.


“Axar was the first choice but had to undergo recovery and hence Kuldeep was a back-up,” a BCCI source said. “Now Axar is fit and back so Kuldeep has been released,” the source added.


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK